Drug intelligence / Profile preview

STONULL

Development stage: Unknown
Lead developer: Krishlar Pharmaceutical
Modality: Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration: Oral

Overview

STONULL is an Ayurvedic capsule formulation developed and marketed by Krishlar Pharmaceutical, an Indian pharmaceutical company. It is specifically indicated for the management of urinary calculi (kidney stones) and urinary stones. As a polyherbal Ayurvedic preparation, it is designed to facilitate the breakdown and natural passage of stones through the urinary tract, likely employing traditional lithontriptic and diuretic herbs. The product is administered orally and is marketed within the company's portfolio of herbal and Ayurvedic remedies, alongside other stone-related products such as UROKRIT.

Brand names: STONULL
Other names: STONULL Capsule

Beyond the preview

Go deeper on STONULL.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on STONULL.

Explore the full profile